ROS1 Gene Rearrangement
7 clinical trials · Condition
◉ Watch ROS1 Gene Rearrangement
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab, Lenvatinib and Chemotherapy After TKIs in NSCLC (NCT04989322) | Dr Joanne CHIU | 2021-10-05 |
| Study of Crizotinib for ROS1 and MET Activated Lung Cancer (NCT04084717) | University Health Network, Toronto | 2019-12-03 |
| X-396 Capsule in Advanced NSCLC Patients With ROS1 Gene Rearrangement (NCT03608007) | Betta Pharmaceuticals Co., Ltd. | 2018-06-15 |
| Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer (NCT02321501) | M.D. Anderson Cancer Center | 2016-06-22 |
Track ROS1 Gene Rearrangement automatically
Every clearance here is in the API, with alerts when new ones post.